This report is a summary of the results obtained from various molecular respiratory panels performed across PathCare laboratories during August 2025 (epidemiological weeks 32-35). The data is dependent on submission of samples by clinicians and therefore may not be...
As we continue further into the multidrug resistant era, it becomes necessary to develop a deeper understanding of how to perform and interpret antimicrobial susceptibility testing. The clinical microbiology laboratory provides valuable susceptibility data that can...
PathCare introduces Xpert MTB/XDR testing as a reflex test for rapid molecular drug susceptibility testing of rifampicin-resistant Mycobacterium tuberculosis (RR-TB) positive clinical samples South Africa remains one of the top 30 high-burden countries for...
This report is a summary of the results obtained from various molecular respiratory panels performed across PathCare laboratories during July 2025 (epidemiological weeks 27-31). The data is dependent on submission of samples by clinicians and therefore may not be...
